ArticleFrontiers in oncology2026

Case Report: Glomerular microangiopathy and reversible renal toxicity during prolonged bevacizumab therapy in ovarian cancer.

Jungheon Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.